Get my own profile
Public access
View all4 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Thomas E. Cheatham, IIIProfessor of Medicinal Chemistry; Director Research Computing; University of UtahVerified email at utah.edu
- David A CaseRutgers UniversityVerified email at biomaps.rutgers.edu
- David M FergusonProfessor of Medicinal Chemistry University of MinnesotaVerified email at umn.edu
- Thomas A DardenSenior Scientist OpenEye Cadence Molecular SciencesVerified email at eyesopen.com
- Carlos SimmerlingMarsha Laufer Chair in Physical & Quantitative Biology, SUNY Stony BrookVerified email at stonybrook.edu
- Kenneth M. Merz Jr.Staff, Lerner Research Institute; Professor, Michigan State UniversityVerified email at msu.edu
- Michael F CrowleyPrincipal Scientist, National Renewable Energy LaboratoryVerified email at nrel.gov
- Woody ShermanPsivant TherapeuticsVerified email at psivant.com
- Chris ChipotUniversity of Lorraine — University of Illinois, Urbana-ChampaignVerified email at Univ-Lorraine.fr
- Ross C WalkerVerified email at sdsc.edu
- Junmei WangProfessor of computational chemistry/biology, School of Pharmacy, University of PittsburghVerified email at pitt.edu
- Mark A. MurckoRelay TherapeuticsVerified email at relaytx.com
- Kai ZhuSenior Director at BeiGeneVerified email at beigene.com
- Tyler DaySchrodinger, Inc.Verified email at schrodinger.com
- lee pedersenemeritus professor of chemistry, university of north carolina at chapel hillVerified email at ad.unc.edu
- Anuradha CholletiSchrodingerVerified email at schrodinger.com
- Noeris SalamSchrodingerVerified email at schrodinger.com